Torrent Pharmaceuticals (TORNTPHARM) — Board Meeting

Torrent Pharmaceuticals' Securities Transfer and Stakeholders Relationship Committee approved issuance of ₹12,500 crores in Secured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs) via private placement in one or more tranches. The NCDs will be listed on NSE's Wholesale Debt Market Segment with first-ranking exclusive charge over designated accounts and specified trademarks providing 1.1x minimum security cover. Coupon rates and allotment timelines will be determined at issuance.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does this board meeting affect Torrent Pharmaceuticals Limited's outlook?" "What did Torrent Pharmaceuticals Limited announce on 5 January 2026?" "Is this positive or negative for TORNTPHARM?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 5 January 2026

POLYCAB Polycab India Limited Announcement OFSS Oracle Financial Services Software Limited Announcement AXISBANK Axis Bank Limited Insider Trading HDFCBANK HDFC Bank Limited Insider Trading HINDUNILVR Hindustan Unilever Limited Corporate Action INDUSINDBK IndusInd Bank Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.